Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 1.00 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.69 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.62 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3356307 | 0.84 | FDPS (0.71) | FDPSGGPS1BTN3A1PDE3A | |
| SCHEMBL5897909 | 0.84 | FDPS (0.71) | FDPSGGPS1BTN3A1PDE3A | |
| SCHEMBL7606373 | 0.83 | FDPS (0.70) | FDPSGGPS1BTN3A1PDE3ACYP1A2 | |
| SCHEMBL13431339 | 0.82 | GGPS1 (1.00) | FDPSGGPS1BTN3A1PDE3A | |
| SCHEMBL3357622 | 0.82 | GGPS1 (0.82) | FDPSGGPS1BTN3A1PDE3A | |
| SCHEMBL30683242 | 0.81 | FDPS (0.71) | FDPSGGPS1BTN3A1PDE3A | |
| SCHEMBL271001 | 0.81 | FDPS (1.00) | FDPSGGPS1BTN3A1PDE3A | |
| SCHEMBL3075655 | 0.80 | FDPS (0.67) | FDPSGGPS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL7264380 | 0.80 | FDPS (0.67) | FDPSGGPS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL13458846 | 0.80 | GGPS1 (0.78) | FDPSGGPS1BTN3A1PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0819164-B2 | DETERGENT COMPOSITION COMPRISING SOURCE OF HYDROGEN PEROXIDE AND PROTEASE ENZYME | PROCTER & GAMBLE (US) | 2013-03-13 | — | — | EP | claimed |
| EP-1639064-A1 | FABRIC ARTICLE TREATING PROCESS | The Procter & Gamble Company (US) | 2006-03-29 | — | — | EP | claimed |
| EP-0819164-B1 | DETERGENT COMPOSITION COMPRISING SOURCE OF HYDROGEN PEROXIDE AND PROTEASE ENZYME | PROCTER & GAMBLE (US) | 2005-07-27 | — | — | EP | claimed |
| WO-2005003267-A1 | FABRIC ARTICLE TREATING PROCESS | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-13 | — | — | WO | claimed |
| US-20050000031-A1 | Fabric article treating system | THE PROCTER & GAMBLE COMPANY | 2005-01-06 | — | — | US | claimed |
| US-20030213503-A1 | Signal-based electrochemical methods for automatic dishwashing | THE PROCTER & GAMBLE COMPANY | 2003-11-20 | — | — | US | claimed |
| US-6017865-A | FOR CLEANING OF SOILED FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-25 | — | — | US | claimed |
| US-5641615-A | USING ACIDIC AQUEOUS SOLUTION OF HYDROGEN PEROXIDE OR PEROXIDE PRECURSOR CONTAINING SULFONIC ACID COMPOUND, WHICH IS FREE OF REHALOGENATING AGENTS AND MULTIVALENT METAL ION COMPLEXES | EASTMAN KODAK COMPANY (US) | 1997-06-24 | — | — | US | claimed |
| WO-1997020911-A1 | DETERGENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-12 | — | — | WO | claimed |
| EP-0778342-A1 | Detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-11 | — | — | EP | claimed |
| EP-0753565-A2 | Detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-15 | — | — | EP | claimed |
| US-4146397-A | Method of forming a photographic image | FUJI PHOTO FILM CO., LTD. (JP) | 1979-03-27 | — | — | US | claimed |
| US-3997348-A | FERRIC SALT BLEACHING SOLUTION | FUJI PHOTO FILM CO., LTD. (JA) | 1976-12-14 | — | — | US | claimed |
| US-20230181605-A1 | TRIPLE COMBINATION THERAPY FOR ENHANCING CANCER CELL KILLING IN CANCERS WITH LOW IMMUNOGENICITY | BEYONDSPRING PHARMACEUTICALS INC (US) | 2023-06-15 | — | — | US | disclosed |
| US-20230181605-A1 | TRIPLE COMBINATION THERAPY FOR ENHANCING CANCER CELL KILLING IN CANCERS WITH LOW IMMUNOGENICITY | BEYONDSPRING PHARMACEUTICALS INC (US) | 2023-06-15 | — | — | US | disclosed |
| WO-2021225908-A1 | TRIPLE COMBINATION THERAPY FOR ENHANCING CANCER CELL KILLING IN CANCERS WITH LOW IMMUNOGENICITY | BEYONDSPRING PHARMACEUTICALS, INC. (US) | 2021-11-11 | — | — | WO | disclosed |
| US-4142895-A | A-AMINOCARBONYL COMPOUND, ORGANOPHOSPHONIC ACID, AND AN AMINOCARBOXYLIC ACID; OXIDATION RESISTANCE | AGFA GEVAERT AKTIENGESELLSCHAFT (DE) | 1979-03-06 | — | — | US | disclosed |
| US-3997348-A | FERRIC SALT BLEACHING SOLUTION | FUJI PHOTO FILM CO., LTD. (JA) | 1976-12-14 | — | — | US | disclosed |
| US-3956536-A | Surface pretreatment of steel prior to enameling | HENKEL & CIE G.M.B.H. (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3951665-A | Direct-positive silver halide emulsion fogged with a tin (II) chelate | CIBA-GEIGY AG (CH) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181605-A1 | TRIPLE COMBINATION THERAPY FOR ENHANCING CANCER CELL KILLING IN CANCERS WITH LOW IMMUNOGENICITY | CD274, PDCD1, PDCD1LG2 | FDPS 273/4885GGPS1 1205/4885BTN3A1 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.